The drug maker reported an 18.32 per cent YoY rise in its consolidated net profit at Rs 297 crore compared with Rs 251 crore in the year-ag...

The company has received a domestic order of Rs 216 crore for the supply of coated CS (carbon steel) pipes for oil and gas sector to be exe...

The company had posted a net loss of Rs 152 crore for the corresponding period of the previous financial year.

The brokerage believes that the valuation premium is untenable with the risks to near-term growth remaining underappreciated and therefore ...

Stating that company's investigations into testing results were inadequate, the letter said this is a repeat observation from USFDA's April...

Hold Torrent Pharmaceuticals Ltd. at a price target of Rs 1740.0 .

The scrip was trading 2.59 per cent lower at Rs 1,623 on the NSE.

Here are a few stocks which may buzz the most in today’s trade.

Torrent Pharmaceuticals is a largecap company, operating in pharmaceuticals and health care sector.

The audit at Indrad plant of the company was carried out by the United States Food and Drug Administration (USFDA) in April.

Torrent Pharmaceuticals and Novo Nordisk began their partnership 25 years ago in 1992 with the manufacture and launch of insulin in 40 IU v...

CLSA said Torrent has made continued progress in its key branded generic markets of India and Brazil, which collectively account for half o...

Glochem is a medium-sized company that makes bulk drugs, or active ingredients, which are used as raw material for medicines.

Last week, Torrent Pharma had said its third manufacturing plant in Gujarat has obtained the Establishment Inspection Report (EIR) from the...

With the approval, this plant is now the third plant of Torrent Pharma to receive USFDA approval, out of its 5 manufacturing plants.

Torrent Pharmaceuticals is seeking shareholders' approval to increase its borrowing limits to Rs 5,000 crore.

It’s all about expansion at Torrent Group, which has interests in pharma and power.